Clinical trial
Aerosol Therapy With High Flow Nasal Cannula (HFNC) in Obese COPD Patients. Aerosol Deposition Pattern and Predictive Values.
NCT03031093 is registered in ClinicalTrials.gov with Universidade Federal do Rio Grande do Norte as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Aerosol Therapy With High Flow Nasal Cannula (HFNC) in Obese COPD Patients. Aerosol Deposition Pattern and Predictive Values.
- Lead sponsor
- Universidade Federal do Rio Grande do Norte
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 2, 2017
- Completion date
- May 5, 2018
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic obstructive pulmonary disease moderate, obesity